The above results confirmed that hUC-MSC-EVs can regulate AP2A1 and AP2B1 through the synaptic vesicle cycle signalling pathway, thus affecting the endocytic effect of SVs and alleviating AD. The gene discussed is AP2B1; the disease is Alzheimer disease.